The Food & Drug Administration (FDA) has allowed for comments to be provided on their proposed rule to codify new requirements on entries filed through U.S. Customs Automated Commercial Environment (ACE).  Comments include (1) Processing times increasing by 50% under ACE; (2) Staffing increases of 40% required to timely process shipments; (3) New data elements being unnecessary or duplicative; (4) Concerns that current optional ACE elements will become mandatory, making matters worse.  Various members of the trade comments with detail: https://www.regulations.gov/docket?dct=FR+PR+N+O+SR&rpp=10&po=0&D=FDA-2016-N-1487